NeuroMetrix Announces Issuance of New U.S. Patent for DPNCheck Point-of-Care Neuropathy Test Technology Medical Device Investing
Exelixis Announces CELESTIAL Phase 3 Pivotal Trial Results Published in The New England Journal of Medicine Biotech Investing
Zynerba Pharmaceuticals Announces Top Line Results from ZYN001 THC-Prodrug Patch Phase 1 Study Life Science Investing
Theratechnologies Announces Financial Results for the Second Quarter of 2018 Pharmaceutical Investing
NanoSphere Health Sciences To Report Revenue and Significant Sales Growth in Second Quarter Cannabis Investing News
